An international team of researchers including experts at the Indiana University School of Medicine has identified a protein found in the brains of people with frontotemporal dementia (FTD), discovering a new target for potential treatments for the disease.
Indiana University researchers are collaborating on a novel approach to use neuroimaging and network modeling tools—previously developed to analyze brains of patients in the clinic—to investigate Alzheimer’s disease progression in preclinical animal models.
Researchers at Indiana University School of Medicine will play key roles in a national consortium led by Wake Forest University School of Medicine to study the use, interpretation and implementation of biomarkers to diagnose Alzheimer’s disease.
An Indiana University School of Medicine statewide project in collaboration with Indiana University Health was recently funded to support people living with dementia as well as their family care partners find more support and resources, thanks to a new $686,000 grant from the National Institute on Aging IMPACT Collaboratory.
Researchers from Indiana University School of Medicine will have a large presence and leadership role at the upcoming Alzheimer’s Association International Conference 2023 in Amsterdam, Netherlands, with involvement in more than 150 presentations at the four-day meeting.
Liana G. Apostolova, MS, MD, FAAN, has been named associate dean for Alzheimer’s disease research at Indiana University School of Medicine. The role is a newly established leadership position on the research cabinet of Tatiana Foroud, PhD, executive associate dean for research affairs at the school.
Researchers at Indiana University School of Medicine are co-leading a 5-year, $41 million study to better understand the biological pathways underlying Alzheimer’s disease and ultimately create more personalized patient care.